See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Invesco S&P SmallCap 600 Pure Growth ETF (RZG) - free report >>
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Invesco S&P SmallCap 600 Pure Growth ETF (RZG) - free report >>
Image: Bigstock
Small-Cap Growth ETF (RZG) Hits New 52-Week High
For investors seeking momentum, Guggenheim S&P SmallCap 600 Pure Growth ETF (RZG - Free Report) is probably on radar now. The fund just hit a 52-week high and is up nearly 25.2% from its 52-week low price of $98.02/share.
But are more gains in store for this ETF? Let’s take a quick look at the fund and the near-term outlook on it to get a better idea on where it might be headed.
RZG in Focus
This ETF tracks the S&P SmallCap 600 Pure Growth Index, which measures the performance of securities that exhibit strong growth characteristics. Enanta Pharmaceuticals, BioTelemetry and Supernus Pharmaceuticals are the top three stocks of the fund. Health Care (27.9%), Information Technology (23.6%) and Consumer Discretionary (15.1%) are the top three sectors. The product charges 35 bps in fees (see all Small Cap ETFs here).
Why the Move?
The small-cap segment has been outperforming lately given the strength in the U.S. dollar, trade tensions and geopolitical worries. Economic well-being at the domestic land is seen as beneficial for small-cap stocks. Since the U.S. economy has been performing better than several other developed economies, this small-cap growth ETF has hit a high lately.
More Gains Ahead?
The fund has a Zacks Rank #3 (Hold). However, it seems that the fund will perform decently in the near term given a positive weighted alpha of 22.70.
Want key ETF info delivered straight to your inbox?
Zacks’ free Fund Newsletter will brief you on top news and analysis, as well as top-performing ETFs, each week. Get it free >>